Annual EBITDA
$23.50B$11.91B+102.87%
Summary
- Current Value
- As of today, PFE annual EBITDA is $23.50B, up +102.87% on
- Historical Performance
- PFE annual EBITDA is down -9.58% over the past 3 years, and up +76.58% over the past 5 years
- All-Time High Comparison
- PFE annual EBITDA is currently -44.86% below its historical high of $42.61B set on
- 3-Year Low Comparison
- PFE annual EBITDA is +102.87% above its 3-year low of $11.58B reached on
- Sector Comparison
- PFE annual EBITDA is higher than 99.75% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $23.50B | +102.9% | -9.6% | +76.6% | +13.2% | |
| Quarterly EBITDA | $7.19B | +7.0% | -33.9% | +94.0% | +5.5% | |
| TTM EBITDA | $26.15B | +53.5% | -35.9% | +73.0% | +0.4% | |
| Price | $25.11 | -6.3% | -47.5% | -31.9% | +45.2% | |
| PE Ratio | 14.63 | -23.2% | +67.4% | -35.4% | -12.8% | |
| Annual Revenue | $63.63B | +6.8% | -21.7% | +54.5% | +27.2% | |
| Annual EPS | $1.41 | +276.4% | -63.7% | -50.9% | +14.4% | |
| Annual EBIT | $16.48B | +211.5% | -20.7% | +119.5% | +3.0% | |
| Annual Net Income | $8.05B | +270.7% | -64.2% | -25.9% | -6.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $42.61B | N/A | -44.9% |
| 5Y | $42.61B | -44.9% | |
| All | $42.61B | -44.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $11.58B | +102.9% | |
| 5Y | $11.58B | +102.9% | |
| All | $576.70M | +3974.2% |
EBITDA History
FAQ
What is the current annual EBITDA of PFE?
As of today, PFE annual EBITDA is $23.50B
What is 1-year change in PFE annual EBITDA?
PFE annual EBITDA is up +102.87% year-over-year
What is 3-year change in PFE annual EBITDA?
PFE annual EBITDA is down -9.58% over the past 3 years
How far is PFE annual EBITDA from its all-time high?
PFE annual EBITDA is currently -44.86% below its historical high of $42.61B set on December 31, 2022
How does PFE annual EBITDA rank versus sector peers?
PFE annual EBITDA is higher than 99.75% of companies in Healthcare sector
When is PFE next annual earnings release?
The next annual earnings release for PFE is on
Quarterly EBITDA
$7.19B$1.99B+38.31%
Summary
- Current Value
- As of today, PFE quarterly EBITDA is $7.19B, up +38.31% on
- Historical Performance
- PFE quarterly EBITDA is up +6.98% year-over-year, and down -33.91% over the past 3 years
- All-Time High Comparison
- PFE quarterly EBITDA is currently -49.07% below its historical high of $14.12B set on
- 3-Year Low Comparison
- PFE quarterly EBITDA is +597.37% above its 3-year low of -$1.45B reached on
- Sector Comparison
- PFE quarterly EBITDA is higher than 99.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $7.19B | +38.3% | +7.0% | -33.9% | +94.0% | |
| Annual EBITDA | $23.50B | – | +102.9% | -9.6% | +76.6% | |
| TTM EBITDA | $26.15B | +1.8% | +53.5% | -35.9% | +73.0% | |
| Price | $25.11 | +1.5% | -6.3% | -47.5% | -31.9% | |
| PE Ratio | 14.63 | +1.5% | -23.2% | +67.4% | -35.4% | |
| Quarterly Revenue | $16.65B | +13.7% | -5.9% | -26.4% | +62.0% | |
| Quarterly EPS | $0.62 | +22.6% | -21.0% | -58.9% | +137.6% | |
| Quarterly EBIT | $5.53B | +54.7% | +11.3% | -43.0% | +121.2% | |
| Quarterly Net Income | $3.55B | +22.3% | -20.8% | -58.9% | +287.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.52B | N/A | -4.3% |
| 3Y | $8.17B | -12.0% | |
| 5Y | $14.12B | -49.1% | |
| All | $14.12B | -49.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.20B | +38.3% | |
| 3Y | -$1.45B | +597.4% | |
| 5Y | -$1.45B | +597.4% | |
| All | -$3.21B | +324.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of PFE?
As of today, PFE quarterly EBITDA is $7.19B
What is PFE quarterly EBITDA most recent change?
PFE quarterly EBITDA was up +38.31% on September 28, 2025
What is 1-year change in PFE quarterly EBITDA?
PFE quarterly EBITDA is up +6.98% year-over-year
How far is PFE quarterly EBITDA from its all-time high?
PFE quarterly EBITDA is currently -49.07% below its historical high of $14.12B set on June 1, 2022
How does PFE quarterly EBITDA rank versus sector peers?
PFE quarterly EBITDA is higher than 99.73% of companies in Healthcare sector
When is PFE next earnings release?
The next earnings release for PFE is on
TTM EBITDA
$26.15B$469.00M+1.83%
Summary
- Current Value
- As of today, PFE TTM EBITDA is $26.15B, up +1.83% on
- Historical Performance
- PFE TTM EBITDA is up +53.51% year-over-year, and down -35.89% over the past 3 years
- All-Time High Comparison
- PFE TTM EBITDA is currently -39.33% below its historical high of $43.10B set on
- 3-Year Low Comparison
- PFE TTM EBITDA is +194.95% above its 3-year low of $8.87B reached on
- Sector Comparison
- PFE TTM EBITDA is higher than 99.55% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $26.15B | +1.8% | +53.5% | -35.9% | +73.0% | |
| Annual EBITDA | $23.50B | – | +102.9% | -9.6% | +76.6% | |
| Quarterly EBITDA | $7.19B | +38.3% | +7.0% | -33.9% | +94.0% | |
| Price | $25.11 | +1.5% | -6.3% | -47.5% | -31.9% | |
| PE Ratio | 14.63 | +1.5% | -23.2% | +67.4% | -35.4% | |
| TTM Revenue | $62.79B | -1.6% | +3.9% | -37.1% | +46.3% | |
| TTM EPS | $1.72 | -8.7% | +130.6% | -67.0% | +21.0% | |
| TTM EBIT | $19.45B | +3.0% | +91.8% | -45.9% | +91.5% | |
| TTM Net Income | $9.84B | -8.7% | +128.5% | -67.2% | +73.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $26.15B | at high | |
| 3Y | $43.10B | N/A | -39.3% |
| 5Y | $43.10B | -39.3% | |
| All | $43.10B | -39.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $24.09B | +8.6% | |
| 3Y | $8.87B | +194.9% | |
| 5Y | $8.87B | +194.9% | |
| All | -$2.20B | +1290.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of PFE?
As of today, PFE TTM EBITDA is $26.15B
What is PFE TTM EBITDA most recent change?
PFE TTM EBITDA was up +1.83% on September 28, 2025
What is 1-year change in PFE TTM EBITDA?
PFE TTM EBITDA is up +53.51% year-over-year
How far is PFE TTM EBITDA from its all-time high?
PFE TTM EBITDA is currently -39.33% below its historical high of $43.10B set on December 31, 2022
How does PFE TTM EBITDA rank versus sector peers?
PFE TTM EBITDA is higher than 99.55% of companies in Healthcare sector
When is PFE next earnings release?
The next earnings release for PFE is on
EBITDA Formula
Data Sources & References
- PFE Official Website www.pfizer.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/78003/000007800325000150/0000078003-25-000150-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/78003/000007800325000054/0000078003-25-000054-index.htm
- PFE Profile on Yahoo Finance finance.yahoo.com/quote/PFE
- PFE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pfe